The dismissal came after studies used to support the MDMA effort "missed serious side ... path to creating access to safe, ...

A UCLA Health analysis of MDMA-assisted therapy research suggests that the drug could improve outcomes of treatment of a wider range of trauma-related conditions experienced by military personnel ...

One of the biggest stories of last year was Lykos Therapeutics’ failure to get its MDMA candidate over the finish line for ...

PsychedeliCare, a movement that includes health care professionals, academics and advocates, launched the psychedelic therapy ...

Lykos Therapeutics is currently working out ways to fund an additional Phase III study for its MDMA-assisted PTSD therapy ...

Mental health professionals have made great advancements in the therapeutic use of psychedelic drugs in recent years. Some substances — like psilocybin, found in magic mushrooms; LSD; and MDMA ...

The 90-subject study found that after three MDMA-assisted therapy sessions, 67% of participants with PTSD no longer qualified for that diagnosis, while 88% experienced a significant reduction in ...

People of color have been underrepresented in these studies for many reasons, says Williams, who designed her study at UConn Health to specifically look at the effects of MDMA-assisted therapy in ...

Psychedelic therapy is being called a ‘frontier’ field of medicine, and now Edmonton has a new psychedelic assisted mental health treatment clinic. But psychiatrists warn there are still unanswered ...

Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...

In 2017, the FDA granted MDMA-assisted therapy Breakthrough Therapy designation, indicating that the therapy is a significant improvement over existing treatments. But so far, MDMA-assisted ...

Clinical trials of MDMA-assisted therapy in treating patients with PTSD suggest it may improve their ability to tolerate treatment and reduce dropout rates, Dunn said. The results from these ...